Funding Opportunities & Notices

NEI Audacious Goals Initiative (AGI)

The Audacious Goals Initiative (AGI) for Regenerative Medicine is an effort by NEI to push the boundaries of vision science and restore vision through regeneration of the retina.

NIH Regenerative Medicine Innovation Project

The Regenerative Medicine Innovation Project (RMIP) was established by the 21st Century Cures Act to accelerate progress in the field  by supporting clinical research on adult stem cells, while promoting scientific rigor and protecting patient safety. This initiative is a trans-NIH effort, in coordination with the Food and Drug Administration (FDA).

NIH Common Fund

Congress created the NIH Common Fund in 2006 for research programs that cut across multiple divisions at NIH — and that no one division could tackle on its own. Common Fund programs focus on urgent NIH priorities, emerging scientific opportunities, and pressing challenges in biomedical research.

Expertise & Resources

NEI AMD Integrative Biology Initiative 

The NYSCF Research Institute and the NEI have generated iPSCs from AMD patients, which are available to the vision research community.

Collaboration opportunities with NCATS

The National Center for Advancing Translational Sciences ' (NCATS) Division of Preclinical Innovation that is dedicated to addressing the scientific and technological challenges in the induced pluripotent stem cell (iPSC) field has a state-of-the-art research facility called the Stem Cell Translation Laboratory (SCTL). 

The SCTL is seeking new collaborations to help achieve common goals in iPSC biology in a faster and more coordinated fashion. Prospective collaborators are encouraged to connect with NCATS for timely notification when program updates are announced. Learn more about the proposal process.

Last updated: December 2, 2020